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Abstract Pathophysiological processes associated with 
disturbances in cell and tissue oxidative homeostasis, are 
associated with self-catalyzed process of lipid peroxida-
tion. The end products of lipid peroxidation are reactive 
aldehydes such as 4-hydroxy-2-nonenal (HNE), acting as 
“second messengers of free radicals.” Although reactive 
aldehydes were first recognized only as cytotoxic, new 
evidence has come to light, related to their cell growth 
regulatory functions achieved through cell signaling. The 
variable appearance of HNE in several organs indicates 
that its mode of action might be related to an individual 
cell stress adaptation. The underlying mechanism could 
be that specific mutations and epigenetic changes on one 
hand interfere with hormesis on the other. The precise role 
of oxidative stress and lipid peroxidation in these process-
es still needs more clarification at molecular level. Finally, 
an individual approach to each patient, based on the in-
dividual cell response to stress, opens a new possibility of 
integrative medicine in cancer treatment and strongly sup-
ports modern concepts of personalized medicine.
Our everyday exposure to physical exercise and psychologi-
cal (eg, stress at work) or environmental (eg, pollution, cig-
arette smoke) stress provoke changes on the cellular level 
resulting in excessive production of reactive oxygen species 
(ROS). In addition, ROS are also continuously formed endog-
enously in small amounts during the normal cell metabo-
lism (eg, electron transport chain in mitochondrion). ROS are 
ubiquitous, short-lived chemically-reactive molecules con-
taining oxygen that can react with surrounding molecules at 
the site of formation. Therefore, cells have evolved efficient 
enzymatic and non-enzymatic antioxidant defense mecha-
nisms to deal with ROS. The condition under which anti-
oxidant mechanisms are overwhelmed by ROS is known 
as oxidative stress. Mild oxidative stress occurs on a daily 
basis and is a key factor in maintaining homeostasis. 
However, strong, acute, or chronic oxidative stress occurring 
as a consequence of various harmful conditions (ie, long-
lasting infections, or autoimmune diseases) disrupts this 
delicate homeostasis. The inability to maintain homeostasis 
and deregulated molecular, cellular, and physiological path-
ways, which are activated to repair stress-induced damage, 
results in increased vulnerability, age- and stress-associated 
disorders and the onset of diseases like metabolic syndrome 
and malignant diseases (Figure 1). Due to scope and space 
limitations, this text will focus on the role of oxidative stress 
only in carcinogenesis.
THE EFFECTS OF OXIDATIVE STRESS ON 
MACROMOLECULES
At low physiological levels, ROS are indispensable in nu-
merous biochemical processes, functioning as redox mes-
sengers and important molecules in intracellular signaling. 
In addition to having an important role in cellular differen-
FIGURE 1. Disruption of homeostasis in human body leads to 
development of various oxidative stress-associated diseases in 
a person-dependent manner.
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tiation, proliferation, and apoptosis, ROS are also key play-
ers in inflammatory processes and defense against micro-
organisms. However, at high levels, ROS may oxidize the 
DNA molecule, proteins, lipids, and carbohydrates, medi-
ating numerous redox-mediated pathological conditions. 
This is mostly due to the rapid reactions of free radicals, 
which have unpaired electrons reacting aggressively with 
the nearby macromolecules.
The oxidation of proteins causes the formation of carbo-
nyl groups, mainly on Pro, Arg, Lys, and Thr amino acid 
side chains. The oxidative cleavage of proteins, either by 
the α-amidation pathway or by the oxidation of glutamyl 
side chains also results in generating protein carbonyl de-
rivates (1). A common effect of protein carbonylation is 
the loss or gain of function of target proteins related to 
age-related conditions and various diseases (2). Modifica-
tions of metabolic and structural proteins cause protein 
dysfunction, altering protein processing and trafficking, 
generating tissue damage and, consequently, being an 
underlying pathogenic mechanism for numerous human 
diseases (3).
ROS can oxidatively damage DNA, resulting in oxidized nu-
cleic acid bases, apurinic/apyrimidinic DNA sites, and sin-
gle-strand or double-strand DNA breaks (4). Hydroxyl rad-
ical (OH) reacts with heterocyclic DNA bases by addition 
and abstraction, yielding reactive purine OH-adduct radi-
cals, pyrimidine OH-adduct radicals, and the allyl radical. 
Further reactions of these radicals may result in a variety 
of final products (5). The guanine oxidative product, 8-oxo-
2’-deoxyguanosine (8-oxodG), is one of the best studied 
oxidative lesions and is widely used as a biomarker for oxi-
dative stress and carcinogenesis. Cancer is nowadays con-
sidered as persistent oxidative stress disorder (6).
The mutagenic potential of 8-oxodG is reflected in its mis-
coding properties. Although it can form Watson-Crick base 
pairs with 2-deoxycytidine, it also readily mispairs and 
forms Hoogstein base pairs with 2-deoxyadenosine during 
replication leading to GC→TA mutations (7). These trans-
versions were observed in numerous cancers, such as skin 
and lung cancer, in the ras oncogene and p53 tumor sup-
pressor gene (8,9). Much of the research examining the 
consequences of oxidative damage to DNA focused on 
mutations. However, emerging work clearly showed an ex-
tensive presence of epigenetic changes. When adjacent to 
5’-methyl-cytosine (5-mC), 8-oxodG diminishes the bind-
ing of methyl binding proteins, MBP, as clearly shown for 
MeCP2 (10). On the other hand, the sensitivity of the meth-
yl group of 5’-mC to oxidation, leading to generation of 
5’-hydroxymethylcytosine (5-hmC), was known for a long 
time (11). What was not known at the time of this discovery 
is that the formation of 5-hmC interferes with many events 
in chromatin condensation cascade, resulting in potential-
ly heritable epigenetic alterations. The research on the ac-
tivity of CMV promoter in HeLa cells extracts, showed that 
the presence of 5-hmCs in the gene promoter inhibited 
transcription, while their presence in the gene body did 
not inhibit transcription directly (12).
Other targets of ROS are unsaturated fatty acyl groups in 
membranes or storage lipids. Their ROS-induced peroxida-
tion and breakdown results in the destruction of biomem-
branes. The final products of lipid peroxidation are reac-
tive aldehydes such as 4-hydroxyalkenals and other similar 
α,β-unsaturated aldehydes, among which, of particular 
biochemical and biomedical relevance, are 4-hydroxynon-
enal (HNE), malondialdehyde (MDA), and acrolein (13). A 
large number of these aldehydes were isolated from bio-
logical samples, where they may promote and reinforce 
cell damage induced by oxidative stress. Lipid-derived al-
dehydes are more stable than ROS and they can diffuse 
across membranes and reach targets distant from the ini-
tial site of oxidative injury (2). Such reactive aldehydes are 
subject to Michael addition reactions, with the nucleo-
philic side chains of lysine, histidine, and cysteine residues 
resulting in protein carbonylation (14,15). The aldehydes 
are very effective in binding to DNA, leading to adduct 
formation and eliciting mutagenic effects (13). Michael 
addition of α,β-unsaturated aldehydes to deoxyguanos-
ine yields N(2)-(3-oxopropyl)-dG adducts. Reversible cycl-
ization of N1 with the aldehyde yields 1,N(2)-dG adducts, 
which can interfere with replication and transcription of 
DNA (16,17). It was found that HNE causes G→T transver-
sions in the p53 tumor suppressor gene at codon 249 (18). 
Acrolein-derived 1,N(2)- γ-hydroxypropano deoxyguanos-
ine (γ-HOPdG) blocks mammalian pol δ and pol ε DNA 
polymerases (19). HNE, which triggers apoptosis through 
c-Jun N-terminal kinase (JNK) activation, interacts and in-
creases induction of remaining TGF-β1 pathways in tumor 
cells. Therefore, they become resistant to TGF-β1-mediated 
growth inhibition, thus contributing to inhibition of the 
tumor growth (20). Additionally, HNE plays a role in mod-
ulation of cell growth, differentiation, cell signaling and 
apoptosis (21,22). This small and highly reactive molecule, 
considered to be a second messenger of free radicals 
and major bioactive marker of oxidative stress, acts as a 
strongly reactive molecular link between genome and 
proteome through epigenome (23).
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INVOLVEMENT OF OXIDATIVE STRESS IN 
CARCINOGENESIS
ROS have a dual role in tumor biology (24). The manner 
in which they act depends on both the specific location 
where they are produced and the number of individu-
al ROS. Previously, we have reported the involvement of 
oxidative stress in both tumor progression (25,26) and 
regression (27-29), describing its effect in different ma-
lignancies, namely melanoma B16F10, Ehrlich ascytic 
tumor, and Walker 256 carcinoma (W256). It is well 
known that both genotoxic and non-genotoxic mecha-
nisms modulate gene activity, which occurs – at the level 
of the epigenome, before any detectable structural genet-
ic change (ie, DNA mutations). Oxidative stress is involved 
in both types of mechanisms and it has a very important 
role in the process of carcinogenesis (30). Accordingly, 
rather than structural molecular changes in a specific gene 
or gene cluster, there are “hallmarks of cancer” that enable 
a cell to change its transcription machinery, become ma-
lignant, and metastasize. The reason for these early chang-
es is closely related to aberrant DNA methylation, which 
is considered to be among the earliest changes to occur 
in carcinogenesis. Aberrant DNA methylation is extensive-
ly present in cancer cells as global hypomethylation and 
focal, specific hypermethylation in promoters of tumor 
suppressor genes, leading to their silencing. For example, 
GSTP1 codes for a detoxifying enzyme that catalyzes conju-
gation reactions between potentially damaging oxidants. 
This gene is the most frequently methylated, and, conse-
quentially, silenced, in more than 90% of prostate cancer 
lesions, approximately 70% of high grade neoplasia (PIN) 
lesions, but very rarely in normal prostate and/or benign 
prostatic hyperplasia (PHB) (31). These methylation aber-
rations, resulting in entirely changed gene activity, inevi-
tably lead to key capabilities that have been summarized 
in an anthological review by Hanahan and Weinberg (32) 
as sustained proliferative signaling, evasion of growth sup-
pression, resistance to cell death, replicative immortality, 
induction of angiogenesis, and activation of invasion and 
metastasis. A recent addition to these six core capabilities 
are the deregulation of cellular energetics and metabolism 
as well as the evasion of the immune destruction (33). Oxi-
dative mechanisms possess a potential role at all stages of 
carcinogenesis. In addition to cancer cells, tumors interact 
with a repertoire of normal cells, contributing to the acqui-
sition of hallmark traits by creating a “tumor microenviron-
ment” (34). We found that normal cells in the vicinity of ma-
lignant ones are in particular stressed by HNE or acrolein, 
mostly likely due to the cancer progression and surround-
ing tissue destruction (35,36). On the other hand, cancer 
cells have very dynamic turnover of lipids, thus avoiding 
cytotoxic effects of lipid peroxidation and growth regulat-
ing effects of the reactive aldehydes. This is especially im-
portant for cancer progression because malignant cells of-
ten have reduced antioxidant capacities, if compared with 
the non-malignant counterpart cells, which makes them 
more susceptible to the toxicity of the aldehydes (37,38). 
It is also important to note that for both malignant and 
non-malignant cells, the oxidative homeostasis is cell-spe-
cific, showing extreme variation in the cellular HNE levels 
FIGURE 2. Microphotographs revealing individuality of the cel-
lular 4-hydroxy-2-nonenal (HNE). Although standardized line 
HeLa cells (A) are considered all to be identical, a treatment 
with 50 μM HNE for 30 minutes revealed great differences in 
their individual reactivity to the toxic dose of the aldehyde. 
Thus, while some cells showed membrane lipid peroxidation 
damage (“blebs” indicated by black arrows), their neighbor 
cells did not show any signs of the damage (gray arrows). 
Similarly, 30 minutes after biopsy needle puncture the affected 
liver cells (B) showed strong immunopositivity for HNE (darker 
shade), while their neighbor cells were negative for the alde-
hyde (lighter shade). However, some cells, even remote, began 
generating HNE indicating individual sensitivity of the cells to 
the damage signaling (indicated by the black arrows).
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both in vitro and in vivo and causing differential sensitivity 
of apparently identical cells to oxidative stress (Figure 2). 
Eventually, (dis)balance of oxidative homeostasis in malig-
nant and surrounding nonmalignant cells might be crucial 
in determining the growth characteristics of the cells and 
the spread of oxidative damage mediated by reactive al-
dehydes (39,40).
PERSONALIzED CANCER MEDICINE
It is now evident that, although general mechanisms of 
tumor development and progression can be summarized 
by the acquisition of postulated hallmark capabilities, the 
actual processes taking place in each specific tumor type 
or subtype, or even in some of the tumor cells, are unique 
and specific for each individual patient as well as for each 
cell. It is true that tumor cells, in order to progress, need to 
overcome common obstacles in their way. The way they 
do it is through a distinctive set of epi-mutations, struc-
tural mutations, and various types of adaptations, eg, in 
a state of oxidative stress. Today, we know that different 
parts of tumor exhibit specific cell subpopulations, harbor-
ing differently methylated parts of DNA as well as differ-
ent mutations, possibly serving as driver mutations that 
may become useful for tumors to overcome the effects of 
a specific targeted therapy. Another level of complexity is 
added by the specific characteristics of stromal cells, pro-
ducing high amounts of TGFβ, which promote epithelial-
mesenchymal transition (EMT) during tumorigenesis (41). 
The EMT phenomenon is characterized by the remodeling 
of epithelial cell-cell and cell-matrix adhesion contacts, re-
pression of epithelial markers, induction of mesenchymal 
markers, and the acquisition of motile capacity, leading to 
an invasive form of cancer. This reversible process is close-
ly related to oxidative stress, as very recently shown in an 
experimental model of lung cells exposed to nickel. The 
exposure induced very strong oxidative stress (measured 
through generation of ROS) and ROS-mediated EMT. The 
underlying molecular mechanism was, at least partially, 
hypermethylation of E-cadherin promoter, with its conse-
quential silencing (42).
CONCLUSIONS
Oxidative stress and lipid peroxidation are present in hu-
man body cells throughout life, playing an extremely im-
portant role in survival. Depending on the severity of ox-
idative stress and lipid peroxidation, the effects on cells 
and the organism vary from positive (hormesis) to nox-
ious, which lead to the occurrence of various diseases 
such as cancer (Figure 3). Persistent oxidative stress and 
excess lipid peroxidation cause DNA damage that, along 
with deregulation of cell homeostasis, lead to carcinogen-
esis. Lipid peroxidation acts as a double-edged sword in 
carcinogenesis, exhibiting either a pro- or anti-cancerous 
effect. Lipid-derived reactive aldehydes, in particular HNE, 
act as second messengers of free radicals and as growth-
regulating factors, hence they are of high importance in 
determining oxidative homeostasis on cellular level and 
on the level of the organism. Monitoring the level of oxi-
dative stress should be an obligatory component of per-
sonalized medicine in particular in oncology. to recognize 
specific molecular changes present in a specific tumor (or 
in a subset of tumor cells) of a specific patient at the time 
of the diagnosis, or during therapy. This individualized ap-
proach, based on repeated genetic profiling of a given 
tumor, therapy monitoring, and the possible emergence 
of acquired resistance (43), joined with relevant informa-
tion on the methylome, transcriptome, proteome, and on 
both oxidative stress and lipid peroxidation levels, could 
significantly contribute to an improvement of therapy and 
prognosis in cancer patients. Rapid technological expan-
sion has generated valuable tools for analyzing the tumor 
“global picture.” While high-throughput sequencing and 
microarray techniques might prove helpful in identifying 
possible targets for anticancer therapy, epigenomic and 
proteomic analysis, including aldehyde-adducts, may be 
used for precise identification of specific tumor biomarkers 
as well as markers of response to therapy (44), especially in 
oxidative stress-related malignancies.
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